Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Deals
Nuance Pharma Wins Arbitration, Rescinds Licensing Deal with Antibe Therapeutics
October 20, 2024
Company
Drug
Aosaikang’s Marketing Approval Filing for Delafloxacin Accepted by China’s NMPA
October 20, 2024
Company
Deals
Vivolight Medical Secures Over RMB 100 Million in Strategic Financing to Boost Global Expansion
October 20, 2024
Company
Drug
Huadong Medicine’s Arcalyst Filing for Recurrent Pericarditis Accepted by China’s NMPA
October 20, 2024
Company
Medical Device
Sino Medical Sciences Receives Hong Kong Approval for HT Supreme Drug-Eluting Stent System
October 20, 2024
Company
Drug
Hengrui Pharmaceuticals Gets NMPA Green Light for KRAS G12C Inhibitor Clinical Trial in Advanced Solid Tumors
December 3, 2024
Company
Drug
HitGen Secures CDE Approval for Lipisense IND Filing, Advancing Development for Dyslipidemia Treatment
October 20, 2024
Company
Drug
ViiV Healthcare Presents Phase I Data for Ultra-Long-Acting Cabotegravir in HIV Treatment and Prevention
October 20, 2024
Company
Deals
Merck Teams Up with C4 Therapeutics for Targeted Protein Degraders in Oncology
October 20, 2024
Company
Digital
Innovent Biologics’ Taletrectinib Receives Second NDA Acceptance in China for ROS1 Positive NSCLC
October 20, 2024
Company
Drug
BMS Reports Positive Long-Term Data for Zeposia in Multiple Sclerosis Trials
November 13, 2024
Company
Drug
BeiGene’s Brukinsa Outperforms Acalabrutinib in MAIC for Relapsed/Refractory CLL, Says BeiGene
January 6, 2025
1
2
…
752
753
754
755
756
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?